Sorrento Therapeutics (SRNE)
(Delayed Data from OTC)
$0.02 USD
0.00 (7.14%)
Updated May 3, 2024 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Sorrento Therapeutics, Inc. [SRNE]
Reports for Purchase
Showing records 21 - 40 ( 185 total )
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Additional COVISTIX Positives; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Scilex Spinout Announced; Pipeline Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: What Happens When Omicron Meets Delta?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVI-STIX Bulk Contract Executed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Abivertinib Data Publication; COVISTIX Progress; 3Q21 Financials; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Socazolimab New Drug Application Acceptance in China; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Abivertinib Generates Encouraging Phase 2 COVID-19 Data; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVISTIX Receives CE Mark; Multiple Pipeline Advances; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Top and Bottom-Line Miss; 2Q21 Financial Results; Reducing PT to $26
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: COVID Therapeutics Could Become Super Critical - Why? Look to Lessons from Cancer & Antibiotics
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: COVID Therapeutics Could Become Super Critical Why? Look to Lessons from Cancer & Antibiotics
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Mexican Governmental Agency Relationship Established; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
First DAR-T Candidate Cleared for Clinical Testing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
A Plethora of Pipeline Progressions; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Lots of News Flow An Approval in China, P2 COVID, P3 for Sciatica Pain Management Enrolled, Viva Mexico
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Contagious SARS-CoV-2 Variants Signal Pandemic Persistence; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Resiniferatoxin Cleared to Advance Into Phase 2 Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Knee Pain Non-Opioid Drug Advances to P2 POC Study
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Mexican Regulatory Agency Authorizes COVI-STIX; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R